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We studied a clinical isolate of Salmonella enterica serotype Enteritidis showing resistance to oxyiminocephalosporins. PCR
analysis confirmed the presence of blaCTX-M-14 linked to IS903 in a 95-kb IncI1 conjugative plasmid. Such a plasmid is main-
tained on account of the presence of a pndAC addiction system. Multilocus sequence typing (MLST) analysis indicated that the
strain belongs to ST11. This is the first report of blaCTX-M-14 in Salmonella Enteritidis of human origin in South America.
During the first decade of the 21st Century, there has been arapid worldwide dissemination of CTX-M-derived extended-
spectrum -lactamases (ESBLs) (6). Nevertheless, this process
had begun as early as the 1990s in both Latin America and Europe
(23). In South America, enteropathogens such as Vibrio cholerae
and Salmonella spp. were among the first microorganisms found
to be carrying blaCTX-M-2 (24, 25). After a period of CTX-M-2
prevalence in the region (22, 28), new CTX-M variants started to
be progressively reported worldwide (1, 13, 21).
Salmonella enterica serotype Enteritidis (Salmonella Enteriti-
dis) together with Salmonella enterica serotype Typhimurium are
the main serovars associated with human salmonellosis through-
out the globe, causing digestive tract infections and invasive infec-
tions linked to food-borne diseases (15). Although antibiotic
treatment of gastroenterocolitis (due to microorganisms other
than Shigella spp.) is limited to life-threatening infections in
children, elderly people, or immunocompromised patients,
enteropathogenic microorganisms have already been pointed
out as a reservoir of antibiotic resistance genes (25, 30). In
Uruguay, Salmonella Enteritidis and Salmonella Typhimurium
are the most frequent agents of food-borne diseases (3, 4, 18),
and historically they have remained susceptible to oxyimino-
cephalosporins (3, 18).
In January 2011, a 67-year-old patient with chronic renal fail-
ure but not requiring dialysis was admitted to theHospital Pasteur
of Montevideo, Uruguay, due to a gastroenterocolitis syndrome
that aggravated his renal failure. Stool samples yielded Salmonella
enterica serotype Enteritidis (strain SE1101). Serotyping was con-
firmed at the Centro Nacional de Salmonella (CNS) (18).
The antibiotic susceptibility profile was determined using the
Vitek 2 Compact system (bioMérieux, Marcy l’Étoile, France),
and results were interpreted according to CLSI guidelines (12).
Strain SE1101 was resistant to oxyiminocephalosporins, showing
a clear cefotaximase profile (MIC of cefotaxime, 64 mg/liter;
MIC of ceftazidime, 8mg/liter), but remained susceptible to other
groups of antibiotics, such as aminoglycosides, trimethoprim-sul-
famethoxazole, and fluoroquinolones (Etest MIC of ciprofloxa-
cin, 0.023 mg/liter) (Table 1).
The presence of the blaCTX-M, blaSHV, blaTEM, and blaPER-2
genes was determined according to García-Fulgueiras et al. (13),
obtaining positive PCR results for blaCTX-M group 4 and blaTEM.
Sequencing of PCR products with primers for blaCTX-M-9-related
genes (1) and TEM-FH (5=-CAATAAGCTTCAAAAAGGAAGAG
T-3=) and TEMXhoR (5=-GTGCTCGAGCCAATGCTTAATCAG
TG-3=) confirmed the presence of blaCTX-M-14 and blaTEM-1, re-
spectively. Conjugation assays were carried out using Escherichia
coli J53-2 (rifampin resistant) as the recipient; transconjugants
were selected on MacConkey agar plates supplemented with ri-
fampin (150 mg/liter) and ceftriaxone (1 mg/liter) (26). SE1101
transconjugants (TcSE1101) showed a resistance profile similar to
that of the donor strain and positive PCR results for blaCTX-M and
blaTEM (Table 1). Size estimation of the conjugative plasmid was
carried out by treatment with S1 nuclease (Fermentas, Life Sci-
ences) followed by pulsed-field gel electrophoresis (PFGE), as de-
scribed previously (2).
The probable association of blaCTX-M-14 with insertion se-
quences ISEcp1, IS26, IS903, and ISCR1 was sought by PCR
according to García-Fulgueiras et al. (13). In this regard,
blaCTX-M-14 was found upstream from IS903, which is consis-
tent with previous reports by other authors (5). We were un-
able to detect any association between IS26, ISEcp1, or ISCR1
upstream from blaCTX-M-14.
Plasmid incompatibility group was determined by PCR ac-
cording to Carattoli et al. (9).
Both -lactamases were encoded in a ca. 95-kb IncI1 plasmid
(data not shown). IncI plasmids are considered one of the five
“epidemic resistance plasmids” due to their frequent association
with ESBL genes (7). Nevertheless, only rare reports from Korea
and the United Kingdom have described the association between
IncI plasmids and CTX-M-14 (16, 27). As a rule, IncI plasmids
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have been linked to the dissemination of CMY-2, CTX-M-1, and
TEM-52-lactamases (7). Interestingly, IncI1 plasmids have been
linked to food-borne diseases on account of the high prevalence of
such plasmids in Salmonella isolates of avian origin (8).
The presence of addiction systems encoded in resistance plas-
mids was suggested to allow the maintenance of resistance genes
within a given bacterial population (5, 20). Accordingly, Billard-
Pomares et al. described the presence of blaCTX-M-14 in an FII-FIB
plasmidwith several addiction systems (srnB, pemKI, hokmok sok,
parB, and sopAB) (5). This situation differs from what Mnif et al.
reported, where plasmids bearing blaCTX-M-14 presented only one
or two addiction systems, namely, the pemKI, ccdAB, and hok sok
systems (20). In order to detect mechanisms responsible for plas-
mid maintenance, we also searched for addiction systems in
TcSE1101, by PCR, as reported elsewhere (20); in this regard, we
only detected the presence of the pndAC addiction system.
Recently, Mnif et al. described a clear link between IncI plas-
mids and pndAC addiction systems (20); but so far the available
information concerning the combination of blaCTX-M-14, IncI1
plasmids, pndAC addiction systems, and Salmonella spp. is, to the
best of our knowledge, very rare. The search for the presence of
pndAC in salmonellae in PubMed databases (http://www.ncbi
.nlm.nih.gov/nuccore) yielded only 13 positive results.
However, the acquisition of blaCTX-M-14 by an “epidemic plas-
mid” could mark the beginning of a regional dissemination event
both in salmonellae as well as in other enterobacteria.
Strain SE1101 was genetically characterized by MLST follow-
ing the guidelines described in http://mlst.ucc.ie/mlst/dbs
/Senterica, and the results indicate that it belongs to the sequence
type 11 (ST11; allelic profile, 5,2,3,7,6,6,11). ST11 includes the
majority of the Salmonella Enteritidis isolates uploaded to the S.
entericaMLST database.
Taking into account that IncI1 plasmids are frequently found
in Salmonella isolates of avian origin (8) and that several serovars
other than Enteritidis are more frequent in poultry-derived prod-
ucts in our country (3), we could hypothesize that plasmid
pSE1101 might have been transferred from an animal clone to a
clone associated mainly with human infections.
The detection of blaCTX-M-14 in South America is a recent phe-
nomenon (10, 19, 21): so far, there have been no reports from our
continent about this ESBL in Salmonella spp., although Salmonella
Enteritidis isolates of human origin bearing blaCTX-M-14 have al-
ready been reported, mainly in Spain, China, Japan, and Korea
(11, 14, 17, 27).
The occurrence in Uruguay of ESBL-producing Salmonella
isolates is an extremely rare event; in this sense, in the year 2006,
we reported the presence of blaTEM-144 carried in a transferable
plasmid in Salmonella enterica serotype Derby obtained from eggs
(29), but the clinical relevance of such a finding is still unknown.
Nevertheless, so far in our country, there have been no reports of
ESBLs in Salmonella Enteritidis of human origin.
The fact that this enzyme is encoded in a plasmid that only
confers resistance to -lactamics could be explained by the recent
emergence of this gene in the region and the lack of recombination
events with other genetic structures, as was previously suggested
for the multiresistance plasmid pTN48 (5).
The acquisition of antibiotic resistance genes by agents of gas-
troenteritis (which generally cause mild symptoms that do not
require a medical consult) constitutes a sanitary alert due to the
presence of such genes in the community setting (30). The fact
that Salmonella Enteritidis occurs epidemically, associated with
food-poisoning outbreaks, and that blaCTX-M-14 is carried in a con-
jugative plasmid increases the potential for dissemination of such
gene.
The presence of an addiction system in plasmid pSE1101 could
help with establishing blaCTX-M-14 within a given bacterial popu-
lation as well as increasing the chances of its maintenance in the
bacterial progeny. It is necessary to remain vigilant toward Salmo-
nella antibiotic susceptibility levels in order to minimize the im-
pact of possible outbreaks of this strain or the dissemination of its
plasmid.
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